Skip to content
Market Tracked raises in 2026$3.41B+$183M this week Rounds77 LatestBlue J$176M Series E Thursday, November 12

Parambil

Parambil is AI medical record review software for mass tort and complex litigation.

Trial AI

Trial AI is a Hong Kong-based legal technology platform offering AI mock-court simulations, jurisdiction-specific litigation flow modeling, verdict-style reports, and case-strategy analysis.

Parambil vs Trial AI

At a Glance

DetailParambilTrial AI
CategoryeDiscoveryeDiscovery
Total raised$8MNot disclosed
Rounds tracked2Not disclosed
Latest roundSeed, $6M · Jan 2026Not disclosed
Last valuationNot disclosedNot disclosed
Lead investorsBling Capital, Daybreak VenturesNot disclosed
Built forMid-size firms, BoutiquesNot disclosed
HeadquartersUnited StatesNot disclosed

Funding, Side by Side

Parambil$8M
Trial AIUndisclosed
Parambil rounds
  1. Jan 2026Seed$6M
  2. Jan 2025Pre-Seed$2M
Trial AI rounds

No public rounds tracked yet.

Our Take

We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.

Quick Answers

Which has raised more, Parambil or Trial AI?
Parambil has raised $8M in disclosed funding, compared with no disclosed amount for Trial AI.
What is Parambil best for?
Parambil is AI medical record review software for mass tort and complex litigation.
What is Trial AI best for?
Trial AI is a Hong Kong-based legal technology platform offering AI mock-court simulations, jurisdiction-specific litigation flow modeling, verdict-style reports, and case-strategy analysis.

Source: Legal Tech Circle funding data, from public announcements. Updated November 12, 2026.